相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trial
Xiangwei Yang et al.
BMC CANCER (2022)
DNA damage induced cellular senescence and it's PTEN-armed exosomes-the warriors against prostate carcinoma cells
Sougata Ghosh Chowdhury et al.
MEDICAL ONCOLOGY (2022)
The androgen receptor-lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells
Kimia Mirzakhani et al.
ONCOGENE (2022)
Comprehensive assessment of cellular senescence in the tumor microenvironment
Xiaoman Wang et al.
BRIEFINGS IN BIOINFORMATICS (2022)
Understanding MCL1: from cellular function and regulation to pharmacological inhibition
Monica Sancho et al.
FEBS JOURNAL (2022)
A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer
Dechao Feng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
SIRT1 inhibition-induced senescence as a strategy to prevent prostate cancer progression
Shih-Bo Huang et al.
MOLECULAR CARCINOGENESIS (2022)
The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2
Marzieh Ehsani et al.
ONCOGENE (2022)
Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer
Martina Troiani et al.
NATURE COMMUNICATIONS (2022)
Taking Advantage of the Senescence-Promoting Effect of Olaparib after X-ray and Proton Irradiation Using the Senolytic Drug, ABT-263
Camille Huart et al.
CANCERS (2022)
Cellular senescence and senolytics: the path to the clinic
Selim Chaib et al.
NATURE MEDICINE (2022)
Senescence and cancer - role and therapeutic opportunities
Clemens A. Schmitt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Exploiting senescence for the treatment of cancer
Liqin Wang et al.
NATURE REVIEWS CANCER (2022)
Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer
Thanakorn Pungsrinont et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT
Tao Shen et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Targeting MCL-1 in cancer: current status and perspectives
Haolan Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis
Hui Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
Marzieh Ehsani et al.
CANCERS (2021)
Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy
Valerie Carpenter et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial
Orazio Caffo et al.
EUROPEAN JOURNAL OF CANCER (2021)
Cellular senescence as a possible link between prostate diseases of the ageing male
Gaelle Fiard et al.
NATURE REVIEWS UROLOGY (2021)
Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors
Sophie Bartsch et al.
CANCERS (2021)
The Paradoxical Role of Cellular Senescence in Cancer
Jing Yang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
KDM4 orchestrates epigenomic remodeling of senescent cells and potentiates the senescence-associated secretory phenotype
Boyi Zhang et al.
NATURE AGING (2021)
Mechanisms and significance of therapy-induced and spontaneous senescence of cancer cells
Justyna Mikula-Pietrasik et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer
Taylor C. Peak et al.
MOLECULAR CARCINOGENESIS (2020)
Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer
Xinyi Wang et al.
MOLECULAR ONCOLOGY (2020)
Honing in on PARPi Response in Prostate Cancer: from HR Pathway to Gene-by-Gene Granularity
Alexandra O. Sokolova et al.
CLINICAL CANCER RESEARCH (2020)
Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells
Thanakorn Pungsrinont et al.
CELL AND BIOSCIENCE (2020)
Second-Generation Androgen Receptor Antagonists as Hormonal Therapeutics for Three Forms of Prostate Cancer
Pravien Rajaram et al.
MOLECULES (2020)
Olaparib for Metastatic Castration-Resistant Prostate Cancer
J. de Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives
Gianmarco Leone et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Interleukin-23 Represses the Level of Cell Senescence Induced by the Androgen Receptor Antagonists Enzalutamide and Darolutamide in Castration-Resistant Prostate Cancer Cells
Siddharth Gupta et al.
HORMONES & CANCER (2020)
Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
Miriam Kokal et al.
CANCERS (2020)
DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity
Nicolas Malaquin et al.
CELLS (2020)
Mesenchymal stem cell-derived exosomes suppress proliferation of T cells by inducing cell cycle arrest through p27kip1/Cdk2 signaling
Sunho Lee et al.
IMMUNOLOGY LETTERS (2020)
Senescence and castration resistance in prostate cancer: A review of experimental evidence and clinical implications
Valerie J. Carpenter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases
Lorenzo Cuollo et al.
BIOLOGY-BASEL (2020)
CD44v8-10 mRNA contained in serum exosomes as a diagnostic marker for docetaxel resistance in prostate cancer patients
Taku Kato et al.
HELIYON (2020)
Androgen deprivation therapy with chemotherapy or abiraterone for patients with metastatic hormone-naive prostate cancer: a systematic review and meta-analysis
Guijiang Sun et al.
FUTURE ONCOLOGY (2019)
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells
Maria Sancho-Albero et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells
Nicola Alessio et al.
AGING-US (2019)
Hepatic senescence, the good and the bad
Nazmul Huda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Darolutamide For Castration-Resistant Prostate Cancer
Diogo A. Bastos et al.
ONCOTARGETS AND THERAPY (2019)
Tumor cell escape from therapy-induced senescence
Tareq Saleh et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Halogen-substituted anthranilic acid derivatives provide a novel chemical platform for androgen receptor antagonists
Daniela Roell et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Imatinib enhances the anti-tumour effect of doxorubicin in canine B-cell lymphoma cell line
W. Chen et al.
VETERINARY JOURNAL (2019)
Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells
Maryam Ghashghaei et al.
PROSTATE (2018)
Hsp90 inhibitors as senolytic drugs to extend healthy aging
Heike Fuhrmann-Stroissnigg et al.
CELL CYCLE (2018)
Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard
Nicolas Mottet et al.
EUROPEAN UROLOGY (2018)
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Ekaterina Nevedomskaya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
Haiying Zhang et al.
NATURE CELL BIOLOGY (2018)
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
Kyoko Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis
Jae Won Park et al.
YONSEI MEDICAL JOURNAL (2018)
Structural absorption by barbule microstructures of super black bird of paradise feathers
Dakota E. McCoy et al.
NATURE COMMUNICATIONS (2018)
Apalutamide for the treatment of prostate cancer
Dana E. Rathkopf et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin
Yong Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2018)
H3K14me3 genomic distributions and its regulation by KDM4 family demethylases
Bin Zhao et al.
CELL RESEARCH (2018)
Bipolar Androgen Therapy: A Paradoxical Approach for the Treatment of Castration-resistant Prostate Cancer
Michael T. Schweizer et al.
EUROPEAN UROLOGY (2017)
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients
Marzia Del Re et al.
EUROPEAN UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
Radiation therapy and cancer control in developing countries: Can we save more lives?
Rajamanickam Baskar et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
Effect of enzalutamide on sensitivity in prostate cancer cells to radiation by inhibition of DNA double strand break repair.
Maryam Ghashghaei et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer
Hirotoshi Kawata et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma
A-L Zeng et al.
ONCOGENE (2017)
Isolation of exosomes from whole blood by integrating acoustics and microfluidics
Mengxi Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Mechanisms of Therapeutic Resistance in Prostate Cancer
Mary Nakazawa et al.
CURRENT ONCOLOGY REPORTS (2017)
Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2
Masaki Takasugi et al.
NATURE COMMUNICATIONS (2017)
Identification of HSP90 inhibitors as a novel class of senolytics
Heike Fuhrmann-Stroissnigg et al.
NATURE COMMUNICATIONS (2017)
Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer
Yun Ye et al.
ONCOTARGET (2017)
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer
Liqin Wang et al.
CELL REPORTS (2017)
The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy
Markus Schosserer et al.
FRONTIERS IN ONCOLOGY (2017)
Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy
Michael L. Blute et al.
PLOS ONE (2017)
New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463
Yi Zhu et al.
AGING-US (2017)
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
Girijesh Kumar Patel et al.
BRITISH JOURNAL OF CANCER (2017)
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Jianhui Chang et al.
NATURE MEDICINE (2016)
Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis
Fiona M. Frame et al.
CANCER MEDICINE (2016)
Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors
Yi Zhu et al.
AGING CELL (2016)
Unbiased analysis of senescence associated secretory phenotype (SASP) to identify common components following different genotoxic stresses
Servet Ozcan et al.
AGING-US (2016)
Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
Michael J. Morris et al.
CLINICAL CANCER RESEARCH (2016)
SYNTHETIC LETHAL METABOLIC TARGETING OF CELLULAR SENESCENCE IN PROSTATE CANCER WITH THE REPURPOSED DRUG METFORMIN
Johnathon R. McCormick et al.
JOURNAL OF UROLOGY (2016)
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Andras Kotschy et al.
NATURE (2016)
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
Joanna Kowal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells
Mohsen Esmaeili et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2016)
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
Remi-Martin Laberge et al.
NATURE CELL BIOLOGY (2015)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells
D. J. Barakat et al.
ONCOGENE (2015)
Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer
Taku Kato et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
Alejo Rodriguez-Vida et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity
Umberto Galderisi et al.
Oncotarget (2015)
Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
Sven Perner et al.
ONCOTARGET (2015)
Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts
Ridwana Chowdhury et al.
ONCOTARGET (2015)
Overexpression of the Novel Senescence Marker β-Galactosidase (GLB1) in Prostate Cancer Predicts Reduced PSA Recurrence
Jennifer Wagner et al.
PLOS ONE (2015)
Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway
Julia Roediger et al.
MOLECULAR CANCER (2014)
A Natural Androgen Receptor Antagonist Induces Cellular Senescence in Prostate Cancer Cells
Wiebke Hessenkemper et al.
MOLECULAR ENDOCRINOLOGY (2014)
Evolution of androgen receptor targeted therapy for advanced prostate cancer
Yien Ning Sophia Wong et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer
Kenji Takahashi et al.
FEBS OPEN BIO (2014)
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Hsin-Ho Liu et al.
BIOMEDICINE-TAIWAN (2014)
Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-B activation
Olga Moiseeva et al.
AGING CELL (2013)
Programmed Cell Senescence during Mammalian Embryonic Development
Daniel Munoz-Espin et al.
CELL (2013)
Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning
Mekayla Storer et al.
CELL (2013)
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T. Karantanos et al.
ONCOGENE (2013)
Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells
Dominick G. A. Burton et al.
PLOS ONE (2013)
PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells
Payel Chatterjee et al.
PLOS ONE (2013)
Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo
Jonathan A. Ewald et al.
PROSTATE (2013)
Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer
Javier Guerrero et al.
PROSTATE (2013)
Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells
Robert E. Carraway et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis
Yujiang Fang et al.
CANCER SCIENCE (2012)
The AR dependent cell cycle: Mechanisms and cancer relevance
Matthew J. Schiewer et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
Yu Sun et al.
NATURE MEDICINE (2012)
Decreased Skp2 Expression Is Necessary but Not Sufficient for Therapy-Induced Senescence in Prostate Cancer
Jonathan A. Ewald et al.
TRANSLATIONAL ONCOLOGY (2012)
p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype
Adam Freund et al.
EMBO JOURNAL (2011)
Response of Human Prostate Cancer Cells and Tumors to Combining PARP Inhibition with Ionizing Radiation
Juan Camilo Barreto-Andrade et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Darren J. Baker et al.
NATURE (2011)
Androgen Depletion Induces Senescence in Prostate Cancer Cells through Down-regulation of Skp2
Zuzana Pernicova et al.
NEOPLASIA (2011)
20-Aminosteroids as a novel class of selective and complete androgen receptor antagonists and inhibitors of prostate cancer cell growth
Manolis A. Fousteris et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
DNA Damage-Mediated Induction of a Chemoresistant Niche
Luke A. Gilbert et al.
CELL (2010)
Therapy-Induced Senescence in Cancer
Jonathan A. Ewald et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Bipolar Androgen Therapy: The Rationale for Rapid Cycling of Supraphysiologic Androgen/Ablation in Men With Castration Resistant Prostate Cancer
Samuel R. Denmeade et al.
PROSTATE (2010)
The p53-p21Cip1/WAF1 pathway is necessary for cellular senescence induced by the inhibition of protein kinase CKII in human colon cancer cells
Ji-Young Kang et al.
MOLECULES AND CELLS (2009)
Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network
Arturo V. Orjalo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
A High-Throughput Method to Identify Novel Senescence-Inducing Compounds
Jonathan A. Ewald et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Drug-induced senescence bystander proliferation in prostate cancer cells in vitro and in vivo
J. A. Ewald et al.
BRITISH JOURNAL OF CANCER (2008)
Senescence-associated exosome release from human prostate cancer cells
Brian D. Lehmann et al.
CANCER RESEARCH (2008)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
Chemokine signaling via the CXCR2 receptor reinforces senescence
Juan C. Acosta et al.
CELL (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines
Masashi Takeda et al.
PROSTATE (2007)
E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma
M. E. Crosby et al.
ONCOGENE (2007)
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells
Anjana Bhardwaj et al.
BLOOD (2007)
A dominant role for p53-dependent cellular senescence in radiosensitization of human prostate cancer cells
Brian D. Lehmann et al.
CELL CYCLE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Cellular senescence: when bad things happen to good cells
Judith Campisi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Proteomic identification of the wt-p53-regulated tumor cell secretome
F. W. Khwaja et al.
ONCOGENE (2006)
Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence
Jean-Philippe Coppe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity
Carlotta Petti et al.
CANCER RESEARCH (2006)
Proteomic analysis of factors released from p21-overexpressing tumour cells
Caroline A. Currid et al.
PROTEOMICS (2006)
The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms
C Bavik et al.
CANCER RESEARCH (2006)
C/EBPβ cooperates with RB:E2F to implement RasV12-induced cellular senescence
T Sebastian et al.
EMBO JOURNAL (2005)
The identification of senescence-specific genes during the induction of senescence in prostate cancer cells
SR Schwarze et al.
NEOPLASIA (2005)
Oncogene-induced senescence as an initial barrier in lymphoma development
M Braig et al.
NATURE (2005)
Androgen deprivation therapy for prostate cancer
N Sharifi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Modulation of CXCL14 (BRAK) expression in prostate cancer
SR Schwarze et al.
PROSTATE (2005)
Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors
J Campisi
CELL (2005)
Expression of the survivin gene in prostate cancer: Correlation with clinicopathological characteristics, proliferative activity and apoptosis
H Kishi et al.
JOURNAL OF UROLOGY (2004)
Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer
S Suwiwat et al.
CLINICAL CANCER RESEARCH (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill
GP Bromfield et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2003)
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
CA Schmitt et al.
CELL (2002)
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
BD Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging
A Krtolica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Zn2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells
SR Seo et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression:: Implications for carcinogenesis, senescence, and age-related diseases
BD Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
